$2.19
0.052.34%
Últ. Act.: Nov 6, 4:00 PM
The average analyst price target for CytomX Therapeutics is $10.69, 388.1% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $3.59 to $16. The latest change came on Nov 6, 2026, when Wedbush raised its price target on CytomX Therapeutics from $11 to $12 and kept an Outperform rating.
Price Target Range — 10 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months